Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-14

Clinical Trial Update: Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of Anaphylaxis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating whether dexamethasone can prevent the second phase or biphasic reaction of anaphylaxis, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Anaphylaxis | Phase 1 | Status: RECRUITING